Coronavirus update
We would like to inform all our customers and suppliers that “Hydrokem Aerosols” is regarded as an “Essential Supplier” and, as such, our manufacturing operations remain open.
Hydrokem achieves Gold Award in customer satisfaction
In our 2020 annual customer survey, carried out independently and in compliance with ISO/TS10004:2018 Quality Management System Guidelines, we achieved a Gold Award.
This highlights the focus and commitment we have to servicing our customers.
Hydrokem celebrates its 40th Anniversary
Hydrokem Aerosols was incorporated in September 1979 and to celebrate the 40th Anniversary a day of fun has been organised for all our employees on 3rd October.
Planned activities include team building exercises and a local quiz with prizes aplenty.
This is also an opportunity to thank everyone for their significant contribution to growing the business since we were acquired by Clinimed (Holdings) in February 2018.
Introduction of laser coding for application of 2D barcodes to medical device products
To ensure compliance with new GS1 barcoding requirements for medical devices we have purchased 2 laser coders for applying 2D barcodes and human readable data on to the base of cans.
The new coders will be installed on our aerosol and bag on valve medical device production lines in October.
The laser coders ensure a high quality 2D barcode is applied to every product we manufacture and, by placing the code on the base of the can, minimises or eliminates changes in product artwork for our customers.
This is part of our continuing investment plans at Hydrokem.
New Healthcare Blending Facility
We are building a new dedicated healthcare and medical device blending facility which will commence operation in Q4 2019. The facility has been designed to manufacture a range of liquid based products, including powder suspensions and emulsions, to support the manufacture of healthcare aerosol and bov (bag on valve) products.
The facility will be ATEX rated for managing flammable solvents and products. This development is part of Hydrokem’s ongoing investment programme to increase quality standards and make Hydrokem the first choice for manufacture of healthcare and medical device aerosol and bov products.
